Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?

Journal of clinical immunology - 1 Oct 2021

Guisado Hernández Paloma, Blanco Lobo Pilar, Villaoslada Isabel, de Felipe Beatriz, Lucena José M, Martín Gutierrez Guillermo, Castro María José, Gutiérrez Valencia Alicia, Sánchez Codez María Isabel, Gaboli Mirella, Neth Olaf, Olbrich Peter

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to COVID-19 Drug Treatment
Share to Janus Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nitriles

Share to Pyrazoles

Share to Pyrimidines

Share to SARS-CoV-2

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 34109505
DOI: 10.1007/s10875-021-01081-9
PMCID: PMC8189704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?PMID 34109505Read ↗

Orf Infection in a Patient with Stat1 Gain-of-FunctionSemantic proximity Read ↗

STAT1 Gain-of-Function and Hidradenitis Suppurativa Successfully Managed with BaricitinibSemantic proximity Read ↗

Recurrent Oral Aphtha, Diarrhea, Pneumonia, And Respiratory Distress Since Infancy: STAT1 GOF defectSemantic proximity Read ↗

Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain-of-Function (GOF) Mutations – 10 Children and Review of the LiteratureSemantic proximity Read ↗

SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patientsSemantic proximity Read ↗

Potential drug targets of SARS-CoV-2: From genomics to therapeuticsSemantic proximity Read ↗

Novel STAT1 gain-of-function mutation and suppurative infections.Semantic proximity Read ↗

The emerging plasticity of SARS-CoV-2.Semantic proximity Read ↗

Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations—10 Children and Review of the LiteratureSemantic proximity Read ↗

Infections of the lung: a predictive, preventive and personalized perspective through the lens of evolution, the emergence of SARS-CoV-2 and its pathogenesisSemantic proximity Read ↗

Ruxolitinib Response in an Infant With Very-early-onset Inflammatory Bowel Disease and Gain-of-function STAT1 Mutation.Semantic proximity Read ↗

Lafora disease — from pathogenesis to treatment strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.